Chancellor Donald: Bridging Hematology Innovation and Entrepreneurship to Advance Patient Care
Chancellor Donald, Interim Chief of the Division of Hematology and Medical Oncology at Tulane School of Medicine, President of the Medical Executive Committee at University Medical Center New Orleans, shared a post on LinkedIn:
“As someone who proudly calls New Orleans home, I am thrilled to welcome the American Society of Hematology Annual Meeting to our city.
I am honored to join Mike Eckert, Chairman of Gulf South Angels, for the ASH IGNITE Back to Business Breakfast. The intersection of medicine, innovation, entrepreneurship, and investment is critical to advancing discoveries from the laboratory to the patients who need them most.
If you are attending ASH and are interested in innovation, commercialization, entrepreneurship, or building the next generation of hematology solutions, I hope you’ll join us for what promises to be an engaging and impactful discussion.
This is a unique opportunity to connect with colleagues, innovators, investors, and industry leaders who share a commitment to advancing hematology and improving patient care.
Looking forward to seeing you in New Orleans.”
See more in the Gallery.
Stay updated with Hemostasis Today.
-
Nov 3, 2026, 13:51The Future of Coagulation Diagnostics From Laboratory Testing to Better Patient Care
-
Nov 3, 2026, 13:45Keiyona Coots: Patient Blood Management as a Cornerstone of Safer Healthcare
-
Nov 3, 2026, 13:37Godfred Oduro: Engaging Young Students in Thalassemia and Sickle Cell Disease Awareness
-
Nov 3, 2026, 13:37Saskia Middeldorp: The Use of LMWH in Women With Pregnancy Complications
-
Nov 3, 2026, 13:31Nita Radhakrishnan: MRI T2 Reveals Hidden Cardiac and Hepatic Iron Overload in Thalassemia
-
Nov 3, 2026, 13:21Pete Stibbs: From Scientific Ideas to Clinical Impact
-
Nov 3, 2026, 13:06Backflow-Induced Clot Formation During Red Cell Transfusion – AABB
-
Nov 3, 2026, 12:38Kemal Karaagac: DOACs vs. VKAs in Cerebral Venous Thrombosis
-
Nov 3, 2026, 12:30Pakeeza Arshad: RDW and Bone Marrow Recovery in Hematological Malignancies